Medically Tailored Nutrition & Therapeutic Food Market
完整報告名稱與涵蓋範圍
Medically Tailored Nutrition & Therapeutic Food Market Size, Share & Trends Analysis Report, By Product Type (Oral Nutritional Supplements and Medical Foods, Enteral Tube Feeding Formulas, Medically Tailored Meals and Meal Delivery, Specialized Formulas (Metabolic, Renal, Pediatric and Allergen-Free)), By Condition (Malnutrition, Oncology and Critical Illness, Diabetes, Cardiovascular and Kidney Disease, Gastrointestinal, Dysphagia and Neurological Conditions, Inborn Errors of Metabolism and Pediatric Conditions), By Distribution Channel (Hospitals and Long-Term Care, Home Care, Pharmacies and Direct Delivery, Payer and Health Plan Programs), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The medically tailored nutrition and therapeutic food market covers oral nutritional supplements and medical foods, enteral tube feeding formulas, medically tailored meals and meal delivery and specialised formulas for metabolic, renal, pediatric and allergen-free needs, used across malnutrition, oncology, cardiometabolic, gastrointestinal and metabolic conditions in hospital, home and payer program settings. General wellness foods, dietary supplements and the texture modified food market addressed in an existing InsightAce study are excluded from double counting.
Demand is driven by ageing populations and chronic disease prevalence, by evidence that nutrition intervention reduces readmissions and costs, by food-is-medicine programs in which payers and health systems fund medically tailored meals and by home care growth that moves enteral and oral nutrition out of hospitals. Manufacturers are developing plant-based and whole-food enteral formulas, disease-specific products for kidney, diabetes and oncology, high-protein and dysphagia solutions for older adults and delivery models that integrate nutrition with care management, while meal providers scale through Medicaid and Medicare Advantage benefits. Reimbursement coverage that varies widely by country and product, regulatory definitions of medical foods, clinical evidence requirements and supply chain for refrigerated meals shape growth.
North America and Europe lead reimbursed clinical nutrition, with Japan and China growing through ageing and hospital nutrition programs and Asia Pacific expanding home care. Competition involves clinical nutrition majors, medical food and formula specialists, meal delivery companies and food companies entering therapeutic nutrition.
The InsightAce study delivers revenue forecasts in US$ across all product type, condition, distribution channel and end user and regional segments for 2026-2035, alongside segment-level trend analysis, competitive landscape assessment and detailed company profiling.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Medically Tailored Nutrition & Therapeutic Food Market Snapshot
Chapter 4. Global Medically Tailored Nutrition & Therapeutic Food Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. Product Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
5.2.1. Oral Nutritional Supplements and Medical Foods
5.2.2. Enteral Tube Feeding Formulas
5.2.3. Medically Tailored Meals and Meal Delivery
5.2.4. Specialized Formulas (Metabolic, Renal, Pediatric and Allergen-Free)
Chapter 6. Market Segmentation 2: By Condition Estimates & Trend Analysis
6.1. Condition & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Condition:
6.2.1. Malnutrition, Oncology and Critical Illness
6.2.2. Diabetes, Cardiovascular and Kidney Disease
6.2.3. Gastrointestinal, Dysphagia and Neurological Conditions
6.2.4. Inborn Errors of Metabolism and Pediatric Conditions
Chapter 7. Market Segmentation 3: By Distribution Channel Estimates & Trend Analysis
7.1. Distribution Channel & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Distribution Channel:
7.2.1. Hospitals and Long-Term Care
7.2.2. Home Care, Pharmacies and Direct Delivery
7.2.3. Payer and Health Plan Programs
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. Patients and Caregivers
8.2.2. Hospitals and Care Facilities
8.2.3. Payers, Health Systems and Community Programs
Chapter 9. Medically Tailored Nutrition & Therapeutic Food Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Abbott Laboratories
11.2. Nestle Health Science
11.3. Danone Nutricia
11.4. Fresenius Kabi AG
11.5. Reckitt Benckiser Group plc (Mead Johnson Nutrition)
11.6. B. Braun Melsungen AG
11.7. Otsuka Pharmaceutical Co., Ltd.
11.8. Kate Farms, Inc.
11.9. Functional Formularies
11.10. Real Food Blends
11.11. Mom's Meals (PurFoods)
11.12. Season Health
11.13. Ajinomoto Co., Inc.
11.14. Meiji Holdings Co., Ltd.
11.15. Hormel Health Labs
圖表清單 List of Tables & Figures
Table 1. Global Medically Tailored Nutrition & Therapeutic Food Market Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 1. Global Medically Tailored Nutrition & Therapeutic Food Market Segmentation Overview
Table 2. Global Medically Tailored Nutrition & Therapeutic Food Market Revenue Forecast by Condition, 2026-2035 (US$ Mn)
Figure 2. Global Medically Tailored Nutrition & Therapeutic Food Market Share by Product Type, 2026 & 2035
Table 3. Global Medically Tailored Nutrition & Therapeutic Food Market Revenue Forecast by Distribution Channel, 2026-2035 (US$ Mn)
Figure 3. Medically Tailored Nutrition Continuum from Clinical Formulas to Meal Programs
Table 4. Global Medically Tailored Nutrition & Therapeutic Food Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Global Medically Tailored Nutrition & Therapeutic Food Market Share by Condition, 2026 & 2035
Table 5. North America Medically Tailored Nutrition & Therapeutic Food Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Food-Is-Medicine Program Adoption and Payer Coverage by Region, 2026-2035
Table 6. Europe Medically Tailored Nutrition & Therapeutic Food Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Medically Tailored Nutrition & Therapeutic Food Growth Opportunity Analysis
Table 7. Asia Pacific Medically Tailored Nutrition & Therapeutic Food Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Clinical Nutrition Demand by Condition and Distribution Channel
Table 8. Latin America Medically Tailored Nutrition & Therapeutic Food Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Medically Tailored Nutrition & Therapeutic Food Market Participants
Table 9. Middle East & Africa Medically Tailored Nutrition & Therapeutic Food Market Revenue by Country, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們